Management of locally recurrent nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Management of locally recurrent nasopharyngeal carcinoma

Published:2019-09 Issue: Volume:79 Page:101890
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Lee Anne W.M.,Ng Wai Tong,Chan Jimmy Y.W.,Corry June,Mäkitie Antti,Mendenhall William M.^ORCID,Rinaldo Alessandra,Rodrigo Juan P.,Saba Nabil F.,Strojan Primož^ORCID,Suárez Carlos,Vermorken Jan B.,Yom Sue S.^ORCID,Ferlito Alfio

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference119 articles.

1. Current treatment options for recurrent nasopharyngeal cancer;Suarez;Eur Arch Otorhinolaryngol,2010

2. Management of nasopharyngeal carcinoma: current practice and future perspective;Lee;J Clin Oncol,2015

3. Nasopharyngeal carcinoma;Chua;Lancet,2016

4. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study);Au;Oral Oncol,2018

5. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma;Ng;Int J Radiat Oncol Biol Phys,2011

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44;Neoplasia;2024-10

2. PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

3. Dual role of targeting NAE1 in nasopharyngeal carcinoma: Antitumor effects yet inducing radiotherapy resistance;Heliyon;2024-09

4. Case report: intracranial lesions in a patient with anxiety and depression: tumor recurrence or radiation encephalopathy?;Frontiers in Oncology;2024-08-15

5. Failure patterns and individualized treatment plans of reirradiation for inoperable locally recurrent nasopharyngeal carcinoma;Scientific Reports;2024-08-02